These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3265106)
21. A fixed interval momentary sampling method for assessing on-going behaviours induced by dopamine receptor agonists. Cameron DL; Crosbie J; Crocker AD Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):595-606. PubMed ID: 3265522 [TBL] [Abstract][Full Text] [Related]
22. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats. Leander JD Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555 [TBL] [Abstract][Full Text] [Related]
23. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
24. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats. Asin KE; Montana WE Pharmacol Biochem Behav; 1988 Jan; 29(1):89-92. PubMed ID: 3258427 [TBL] [Abstract][Full Text] [Related]
25. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors. Criswell HE; Mueller RA; Breese GA Eur J Pharmacol; 1989 Jan; 159(2):141-7. PubMed ID: 2495973 [TBL] [Abstract][Full Text] [Related]
26. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain. Kelly E; Nahorski SR Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268 [TBL] [Abstract][Full Text] [Related]
27. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists. Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877 [TBL] [Abstract][Full Text] [Related]
28. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. Imperato A; Di Chiara G Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668 [TBL] [Abstract][Full Text] [Related]
29. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. Barone P; Davis TA; Braun AR; Chase TN Eur J Pharmacol; 1986 Apr; 123(1):109-14. PubMed ID: 2872071 [TBL] [Abstract][Full Text] [Related]
31. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. Fletcher GH; Starr MS Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221 [TBL] [Abstract][Full Text] [Related]
32. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237 [TBL] [Abstract][Full Text] [Related]
33. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. White FJ; Wang RY J Neurosci; 1986 Jan; 6(1):274-80. PubMed ID: 2868077 [TBL] [Abstract][Full Text] [Related]
34. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol. Lublin H; Gerlach J Eur J Pharmacol; 1988 Aug; 153(2-3):239-45. PubMed ID: 3263277 [TBL] [Abstract][Full Text] [Related]
35. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists. White FJ; Hu XT; Brooderson RJ Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272 [No Abstract] [Full Text] [Related]
36. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation. Pifl C; Hornykiewicz O Eur J Pharmacol; 1988 Jan; 146(1):189-91. PubMed ID: 3258244 [No Abstract] [Full Text] [Related]
37. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity. Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270 [TBL] [Abstract][Full Text] [Related]
38. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons. Breese GR; Mueller RA Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260 [TBL] [Abstract][Full Text] [Related]
39. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Morelli M; Di Chiara G Eur J Pharmacol; 1987 Sep; 141(1):101-7. PubMed ID: 3117576 [TBL] [Abstract][Full Text] [Related]
40. Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum. Stoof JC; Kebabian JW Brain Res; 1982 Nov; 250(2):263-70. PubMed ID: 6293642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]